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Joan Gómez-JunyentID
1*, David Paredes2, Juan Carlos HurtadoID3, Ana Requena-
Méndez1, Angel Ruiz2, Maria Eugenia Valls3, Jordi Vila1,3, Jose Muñoz1
1 ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clı́nic—Universitat de Barcelona, Barcelona,
Spain, 2 Donation and Transplant Coordination Section, Hospital Clı́nic–Universitat de Barcelona, Barcelona,





Strongyloides stercoralis is a worldwide disseminated parasitic disease that can be transmit-
ted from solid organ transplant (SOT) donors to recipients. We determined the serological
prevalence of S. stercoralis among deceased individuals from endemic areas considered
for SOT donation, using our institution’s serum bank.
Methodology
Retrospective study including all deceased potential donors from endemic areas of strongy-
loidiasis considered for SOT between January 2004 and December 2014 in a tertiary care
hospital. The commercial serological test IVD-Elisa was used to determine the serological
prevalence of S. stercoralis.
Principal findings
Among 1025 deceased individuals during the study period, 90 were from endemic areas of
strongyloidiasis. There were available serum samples for 65 patients and 6 of them tested
positive for S. stercoralis (9.23%). Only one of the deceased candidates was finally a donor,
without transmitting the infection.
Conclusions
Among deceased individuals from endemic areas considered for SOT donation, seropreva-
lence of strongyloidiasis was high. This highlights the importance of adhering to current rec-
ommendations on screening for S. stercoralis among potential SOT donors at high risk of
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the infection, together with the need of developing a rapid diagnostic test to fully implement
these screening strategies.
Author summary
Strongyloidiasis is a neglected tropical disease caused by a parasite which is endemic in
most parts of the world. It can cause a life-threatening disease among immunosuppressed
individuals and can be transmitted from solid organ transplant donors to recipients. We
retrospectively investigated the prevalence of strongyloidiasis among deceased individuals
from endemic areas who were considered for solid organ transplant donation in our cen-
ter, by performing a serological assay using our institution’s serum bank. We found a high
prevalence of strongyloidiasis among these deceased candidates to donation, but only one
of the six who tested positive was finally a donor, without transmitting the disease to
recipients. Our results should encourage physicians to adhere to current guidelines which
recommend active screening of strongyloidiasis in potential solid organ transplant donors
from endemic areas who may be infected. There is a clear need for a rapid diagnostic test
to fully implement systematic screening among these individuals.
Introduction
Strongyloides stercoralis is a parasitic infection which is endemic in large parts of Latin Amer-
ica, Asia and Africa with an estimated prevalence of more than 400 million infected [1]. Due
to its characteristic life cycle, individuals can carry the infection lifelong with mild or no symp-
toms, unless treated. However, strongyloidiasis can result in a life-threatening disease in
immunosuppressed individuals, such as solid organ transplant (SOT) recipients under immu-
nosuppressive drugs and/or steroids [2].
Most commonly, individuals become infected by contacting infective larvae when walking
barefoot. In recent years, cases of transmission between SOT donors to recipients have been
reported [3–7]. In these reports, strongyloidiasis in donors was commonly missed by physi-
cians, possibly due to asymptomatic carriage and/or failure to diagnose severe forms of the dis-
ease. Prior testing or screening in donors had not been performed.
Currently, the American Society of Transplantation recommends systematic screening of S.
stercoralis in donors and candidate recipients from endemic areas and/or with unexplained eosin-
ophilia [8]. However, the increasing reports of transmission from donors to recipients suggest
that these guidelines may not be followed by all Organ Procurement Organizations (OPO) world-
wide. Data from the New York Organ Donor Network showed a strongyloidiasis serological prev-
alence of 4.3% among 233 eligible potential donors screened [9]. However, there are no other data
published on strongyloidiasis prevalence among deceased donors considered for SOT.
Thus, the aim of this study was to determine the serological prevalence of strongyloidiasis
among candidates to SOT donation from endemic areas in a tertiary care hospital in Spain
with authorization for organ donor procurement and transplantation.
Methods
This is a retrospective study including all deceased individuals from endemic areas for strongy-
loidiasis who were considered for organ donation between January 2004 and December 2014
in Hospital Clı́nic, a tertiary care hospital in Barcelona, Spain. Although the prevalence rates
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are probably very different within continents and countries, including rural and urban areas,
donors born in Latin America, Africa and Asia were considered to be from an endemic area
for strongyloidiasis. The main objective of the study was to determine the seroprevalence of S.
stercoralis among candidates for deceased organ donation. This study was approved by the
hospital’s Ethics Committee.
Since 2004, the Transplantation Coordination Unit has been registering in a database all
deceased individuals who are considered for deceased organ donation. A questionnaire is filled
with demographic data (age, sex and country of origin), comorbidities (arterial hypertension,
diabetes mellitus, HIV and HCV infection) and organ procurement data (cause of death, abso-
lute or relative contraindications for organ donation and organs procured). Deceased organs
are only procured if the donor does not have absolute contraindication for donation like active
disseminated cancer or disseminated infection from any origin, with multiple organ failure,
and after family consent from the deceased donor. Several microbiological serologies are per-
formed to exclude potentially transmittable diseases and a frozen serum sample from all
deceased organ donors remain under custody in the Microbiology Department of the hospital,
for at least 30 years after donation.
Using the serum samples of potential donors from endemic areas for strongyloidiasis, we
performed a S. stercoralis serological test. The commercial test IVD-ELISA (IVD Research,
Carlsbad, CA), which detects IgG antibodies by using somatic antigens from larvae of the para-
site, was used (sensitivity 91.2%, specificity 99.1% [10]). Currently, IVD-ELISA is the available
test in our hospital. The sample is defined as positive if the absorbance/0.2 (i) > 1.1. All ana-
lyzed samples were anonymized.
Stata version 13.1 (Stata Corporation, College Station, TX, USA) was used for statistical
analyses. Categorical variables were described by counts and percentages, whereas continuous
variables were expressed as means and standard deviations (SD) or medians and interquartile
ranges (IQRs).
Results
During the period 2004–2014, 1025 deceased individuals were evaluated as potential deceased
organ donors. Of these, 90 donors (8.78%) were native from endemic areas for strongyloidia-
sis. Most were males (63/90 cases; 70%) and median age of all cases was 41 years old (IQR 33–
51). More than half of the deceased organ donors from endemic areas had been born in Latin
America (49/90 cases; 54.44%), whereas the rest were from Southeast Asia (24/90 cases;
26.67%) and Africa (17/90 cases; 18.89%).
Finally, only in 65 of the 90 cases, available serum samples were found and analysed for S.
stercoralis serology and 6/65 cases (9.23%) were found to have a positive test for strongyloidia-
sis. S. stercoralis serology indices ranged between 1.84 and 9.32. As shown in Table 1, four
were male and age range was between 22 and 62 years. From the 6 positive cases, three individ-
uals were native from Latin America (2 from Brazil and 1 from Ecuador), two from Africa
(Senegal and Ghana) and one from Southeast Asia (Philippines). Between the seropositive
deceased donors, only one was considered suitable for donation and 2 kidneys, two lungs,
heart and liver were procured and transplanted.
Given these results, we investigated whether there had been transmission of strongyloidiasis
to SOT recipients from the infected deceased donor. Transplant units from other centres were
informed and we were only able to evaluate two recipients who were transplanted in our hos-
pital in 2007. They were a 50-year-old and 55-year-old male recipients who had received a kid-
ney and liver transplant, respectively. Strongyloidiasis serology and stool culture were negative
in both recipients.
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Discussion
In this article, we found that the seroprevalence of strongyloidiasis among deceased individuals
from endemic areas who are evaluated as potential donors was high. Apart from the data pub-
lished by Abanyie et al. [9], there are no previous reports of the seroprevalence of strongyloidi-
asis from OPOs’ or Procurement Hospital serum banks.
Strongyloidiasis can be transmitted from donors to SOT recipients, although this is proba-
bly uncommon. The true risk of transmission and related factors are difficult to determine,
although the parasite burden and the stage of the infection could play an important role [7].
However, since most SOT recipients will be immunosuppressed for the rest of their lives, the
possibility of becoming infected by transmission from the donor represents a serious public
health issue.
AST guidelines clearly recommend screening both donors and recipients from endemic
areas [8], but this is probably not universally followed in most procurement hospitals and cen-
ters with SOT programs in USA or Europe, as has been recently published [11]. Reasons for
this may be related with little number of donors and/or recipients native from endemic areas,
the lack of standardized serological tests in some laboratories or economic issues. Despite all
these potential difficulties, physicians in charge of procurement centers and SOT programs
should definitely incorporate AST recommendations when testing for donor-to-recipient
transmissible diseases.
In our hospital, following the present study results and a previous reported case of transmis-
sion [7], screening policies have been redefined. Clinicians in charge of transplantation pro-
grams have been encouraged either to screen potential recipients at risk or refer them to the
Tropical Medicine Department Outpatient Clinic. A similar approach has been suggested for
donors who may undergo elective transplant surgery. Despite clinicians’ awareness of the
problem, more difficulties have been faced in implementing an efficient strongyloidiasis
screening strategy in urgent donations, given the characteristics of these procedures and the
current available diagnostic tests. In every case, a strict protocol is currently followed accord-
ing to the individualized donor’s or recipient’s risk of infection, prompting exhaustive investi-
gations prior or during the SOT donation, with rapid antiparasitic treatment initiation, if
necessary.
Strongyloidiasis, a neglected tropical disease, is one of the most prevalent infections world-
wide. In recent years, it has become an important health problem in non-endemic settings,
where high prevalence in specific populations has been encountered [12, 13]. The increasing
frequency of migration flows of people from endemic areas in recent years may have resulted
in these individuals becoming SOT donors more often. Similarly, many endemic countries
Table 1. Main characteristics, final donation status and serology index among six deceased individuals considered for solid organ donation who tested positive for
strongyloidiasis.
Candidate Year Age/ Sex Country of origin Cause of death Final donation status Serology index
1 2007 62 / F Brazil Head trauma Yes (kidney, liver, lungs, heart) 2.26
2 2008 22 / M Ghana Subarachnoid haemorrhage No (medical contraindication) 2.36
3 2011 36 / M Senegal Cardiovascular No (medical contraindication) 1.84
4 2012 62 / F Philippines Cardiovascular No (organ problems) 9.32
5 2012 38 / M Brazil Cardiovascular No (organ problems) 9.13
6 2012 42 / M Ecuador Head trauma No (judicial refusal) 2.42
F: Female; M: Male.
https://doi.org/10.1371/journal.pntd.0007010.t001
High seroprevalence of Strongyloides stercoralis in SOT donors
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007010 November 29, 2018 4 / 6
have national transplant programs and the number of organ procurements may increase in the
coming years. Clinicians should also take into account that strongyloidiasis has been described
in temperate areas, such as Spain, especially among the elderly [14], who may be potential
recipients prone to develop severe forms if immunosuppressed. All these considerations make
it even more reasonable to incorporate AST recommendations in the daily clinical practice of
deceased and living donors and SOT recipients in endemic and non-endemic settings.
In this line, the available serological tests currently available are far from being optimal
[10]. Two commercial tests (IVD-ELISA and Bordier-ELISA) based on Enzyme-Linked
Immunosorbent Assay (ELISA) are among the most common used tests. These present high
sensitivity (73–100%), which can be lower in immunocompromised individuals [15]. More-
over, these tests show cross-reactivity with other nematode infections, potentially causing
false-positive results. In our study, cross-reactivity was probably limited, since positive samples
had high serological indices [10]. Another limitation of these tests is that they are often time-
consuming and require specific expertise, which may add difficulties to systematic screening
in the urgency of transplantation.
All these inconvenients in the serological diagnosis of strongyloidiasis support the impor-
tance of focusing research efforts on the development of better diagnostic tools in the near
future [16]. It is clear that there is a need for a rapid, validated and robust test, if systematic
screening needs to be implemented among the deceased and living donors and SOT recipient
population.
Our study has several limitations. It was a retrospective study performed in a single centre,
thereby limiting the generalizability of the results. Apart from the high number of missing
serum samples, the lower proportion of individuals from Africa and Asia may have affected
our results. Finally, the existence of false positives due to a co-infection by other nematodes is
also difficult to rule out.
In conclusion, we found a high seroprevalence of strongyloidiasis in individuals from
endemic settings evaluated as potential deceased donors for SOT. Our data reinforce the
importance of following current guidelines recommending systematic screening of potential
donors from endemic areas. More research is urgently needed to develop rapid diagnostic tests
which can be used in daily clinical practice.
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